ASPN and prostate cancer: Although decorin acts as a tumor suppressor and biglycan is regarded as an oncogene, asporin exerts tumor-suppressor function in triple-negative breast cancer but exerts tumor-promotor function in some types of cancer, including breast, pancreatic, colorectal, gastric, and prostate cancer (10).